Literature DB >> 26045089

Cause-Specific Deaths in Non-Dialysis-Dependent CKD.

Sankar D Navaneethan1, Jesse D Schold2, Susana Arrigain3, Stacey E Jolly4, Joseph V Nally5.   

Abstract

CKD is associated with higher risk of death, but details regarding differences in cause-specific death in CKD are unclear. We examined the leading causes of death among a non-dialysis-dependent CKD population using an electronic medical record-based CKD registry in a large healthcare system and the Ohio Department of Health mortality files. We included 33,478 white and 5042 black patients with CKD who resided in Ohio between January 2005 and September 2009 and had two measurements of eGFR<60 ml/min per 1.73 m(2) obtained 90 days apart. Causes of death (before ESRD) were classified into cardiovascular, malignancy, and non-cardiovascular/non-malignancy diseases and non-disease-related causes. During a median follow-up of 2.3 years, 6661 of 38,520 patients (17%) with CKD died. Cardiovascular diseases (34.7%) and malignant neoplasms (31.8%) were the leading causes of death, with malignancy-related deaths more common among those with earlier stages of kidney disease. After adjusting for covariates, each 5 ml/min per 1.73 m(2) decline in eGFR was associated with higher risk of death due to cardiovascular disease (hazard ratio [HR], 1.10; 95% confidence interval [95% CI], 1.08 to 1.12) and non-cardiovascular/non-malignancy diseases (HR, 1.12; 95% CI, 1.09 to 1.14) but not to malignancy. In the adjusted models, blacks had overall-mortality hazard ratios similar to those of whites but higher hazard ratios for cardiovascular deaths. Further studies to confirm these findings and explain the mechanisms for differences are warranted. In addition to lowering cardiovascular burden in CKD, efforts to target known risk factors for cancer at the population level are needed.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  cardiovascular disease; chronic kidney disease; malignancy; mortality

Mesh:

Year:  2015        PMID: 26045089      PMCID: PMC4587705          DOI: 10.1681/ASN.2014101034

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  37 in total

1.  Let's get serious about racial and ethnic disparities.

Authors:  Neil R Powe
Journal:  J Am Soc Nephrol       Date:  2008-06-04       Impact factor: 10.121

2.  Relation between kidney function, proteinuria, and adverse outcomes.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Anita Lloyd; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Marcello Tonelli
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

3.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

4.  Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease.

Authors:  Stephen F Derose; Mark P Rutkowski; Nathan W Levin; In-Lu A Liu; Jiaxiao M Shi; Steven J Jacobsen; Peter W Crooks
Journal:  Kidney Int       Date:  2009-06-10       Impact factor: 10.612

5.  Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study.

Authors:  Tobias Kurth; Paul E de Jong; Nancy R Cook; Julie E Buring; Paul M Ridker
Journal:  BMJ       Date:  2009-06-29

6.  Association of CKD and cancer risk in older people.

Authors:  Germaine Wong; Andrew Hayen; Jeremy R Chapman; Angela C Webster; Jie Jin Wang; Paul Mitchell; Jonathan C Craig
Journal:  J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 10.121

7.  Age affects outcomes in chronic kidney disease.

Authors:  Ann M O'Hare; Andy I Choi; Daniel Bertenthal; Peter Bacchetti; Amit X Garg; James S Kaufman; Louise C Walter; Kala M Mehta; Michael A Steinman; Michael Allon; William M McClellan; C Seth Landefeld
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

8.  Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.

Authors:  Todd A Lee; A Simon Pickard; David H Au; Brian Bartle; Kevin B Weiss
Journal:  Ann Intern Med       Date:  2008-09-16       Impact factor: 25.391

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  White/black racial differences in risk of end-stage renal disease and death.

Authors:  Andy I Choi; Rudolph A Rodriguez; Peter Bacchetti; Daniel Bertenthal; German T Hernandez; Ann M O'Hare
Journal:  Am J Med       Date:  2009-07       Impact factor: 4.965

View more
  36 in total

1.  BP Targets in Older Adults with CKD: Additional Evidence, but Uncertainty Continues.

Authors:  Sankar D Navaneethan; Adam Whaley-Connell
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-14       Impact factor: 8.237

Review 2.  Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.

Authors:  Sehrish Ali; Natasha Dave; Salim S Virani; Sankar D Navaneethan
Journal:  Curr Atheroscler Rep       Date:  2019-06-22       Impact factor: 5.113

3.  Not All Deaths in CKD Are from a Broken Heart.

Authors:  Germaine Wong; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2015-06-04       Impact factor: 10.121

4.  Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.

Authors:  Sankar D Navaneethan; Jesse D Schold; Stacey E Jolly; Susana Arrigain; Matthew F Blum; Wolfgang C Winkelmayer; Joseph V Nally
Journal:  Kidney Int       Date:  2017-07-24       Impact factor: 10.612

5.  Incidence and characteristics of chronic renal replacement therapy in patients with cancer: data from kidney and cancer registries in Basse-Normandie.

Authors:  Clémence Béchade; Olivier Dejardin; Simona Bara; Véronique Bouvier; Anne-Valérie Guizard; Rémy De Mil; Xavier Troussard; Thierry Lobbedez; Guy Launoy
Journal:  J Nephrol       Date:  2016-11-04       Impact factor: 3.902

6.  Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease.

Authors:  Sankar D Navaneethan; Jesse D Schold; Haiquan Huang; Georges Nakhoul; Stacey E Jolly; Susana Arrigain; Raed A Dweik; Joseph V Nally
Journal:  Am J Nephrol       Date:  2016-02-19       Impact factor: 3.754

Review 7.  Medication non-adherence in chronic kidney disease: a mixed-methods review and synthesis using the theoretical domains framework and the behavioural change wheel.

Authors:  Wubshet H Tesfaye; Daniel Erku; Alemayehu Mekonnen; Yonas Getaye Tefera; Ronald Castelino; Kamal Sud; Jackson Thomas; Kehinde Obamiro
Journal:  J Nephrol       Date:  2021-02-09       Impact factor: 3.902

Review 8.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

9.  Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012.

Authors:  Sankar D Navaneethan; Sreedhar Mandayam; Susana Arrigain; Mahboob Rahman; Wolfgang C Winkelmayer; Jesse D Schold
Journal:  Am J Kidney Dis       Date:  2016-04-27       Impact factor: 8.860

10.  Body mass index and causes of death in chronic kidney disease.

Authors:  Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; John P Kirwan; Joseph V Nally
Journal:  Kidney Int       Date:  2016-01-12       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.